Document is current
Any future updates will be listed below
-
Authors
Gaik, C.
Paal, P.
Reuter, DA
Wulf, H.
Vojnar, Benjamin
-
Funding
Funding for this research was provided by:
Philipps-Universität Marburg
- License Information
-
More Information
Article History
Received: 22 April 2025
Accepted: 10 September 2025
First Online: 23 September 2025
Declarations
:
: This study was approved by the Ethics Committee of the Medical Faculty at Philipps University Marburg, Germany (Reference: 23–275 ANZ; approval date: November 9, 2023). The survey was conducted anonymously. Participation was voluntary and implied consent.
: Not applicable.
: The authors declare no competing interests.
: CG declares no conflicts of interest.PP declares no conflicts of interest.DR reports consultancy for Edwards Lifesciences and Philips, and received lecture fees from Edwards Lifesciences and Baxter.HW declares no conflicts of interest.BV reports consultancy for TEVA-ratiopharm and received honoraria for lectures from Edwards Lifesciences, TEVA-ratiopharm, and Vygon.
